Skip to content
Newsroom
Careers
Contact
(732) 640-0058
Search the website
Why Ascendia?
What We Do
Leadership
History
Technologies
LipidSol
EmulSol
AmorSol
NanoSol
Controlled Release
Services
Streamlined Development
Pre-Formulation
Formulation Development
Analytical Services
Small-Scale Formulations
ICH Stability Studies
Manufacturing
Sterile Parenteral Manufacturing
Oral, Liquid, Solid Topic Dosage Manufacturing
GMP and cGMP
Applied Clinical Trial Materials
Our Facility & Equipment
Partner with Ascendia
Search the website
Why Ascendia?
What We Do
Leadership
History
Technologies
LipidSol
EmulSol
AmorSol
NanoSol
Controlled Release
Services
Streamlined Development
Pre-Formulation
Formulation Development
Analytical Services
Small-Scale Formulations
ICH Stability Studies
Manufacturing
Sterile Parenteral Manufacturing
Oral, Liquid, Solid Topic Dosage Manufacturing
GMP and cGMP
Applied Clinical Trial Materials
Our Facility & Equipment
Partner with Ascendia
Newsroom
Careers
Contact
(732) 640-0058
Search the website
Newsroom
First
Prev
1
2
3
Next
Last
Lyophilization Contract Manufacturing Services: What to Know
Jan 12, 2023 12:00:00 AM
Ascendia Pharmaceuticals Will be in Boston for AAPS
Oct 14, 2022 12:00:00 AM
Liposome vs. Lipid Nanoparticle: What’s the Difference?
Jul 28, 2022 12:00:00 AM
Pharmaceutical Nanotechnology: What to Know
Jul 28, 2022 12:00:00 AM
Ophthalmic Formulation Development: Inside Ophthalmic Preparation
Jul 28, 2022 12:00:00 AM
Wet Milling vs. Dry Milling in the Pharmaceutical Industry
Jul 28, 2022 12:00:00 AM
Drug Formulation Development: Quick Reference Guide
Jun 27, 2022 12:00:00 AM
Phase 1 Manufacturing: How to Prepare
Jun 27, 2022 12:00:00 AM
Liquid Capsule Manufacturing: What to Know
Apr 21, 2022 12:00:00 AM
Capsule Formulation Development: From Dosage Forms to Filling
Apr 14, 2022 12:00:00 AM
Liquid Capsules Explained
Apr 4, 2022 12:00:00 AM
Types of Sterile Dosage Forms (and How to Choose)
Mar 20, 2022 12:00:00 AM